Global cancer: overcoming the narrative of despondency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global cancer: overcoming the narrative of despondency

Published:2023-02 Issue:10374 Volume:401 Page:319
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

The Lancet

Publisher

Elsevier BV

Subject

General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Indirect Costs of Absence Associated with Mental Disorders on the Basis of Social Security Data (2012–2023);Healthcare;2024-09-06

2. Self-Assembled Nanoparticles of Silicon (IV)–NO Donor Phthalocyanine Conjugate for Tumor Photodynamic Therapy in Red Light;Pharmaceutics;2024-09-04

3. Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study;Heliyon;2024-03

4. Molecularly imprinted polymers based on attapulgite and sustained-release properties for 5-FU;Colloid and Polymer Science;2024-02-17

5. Exploring binding potential of two new indole alkaloids from Nauclea officinalis against third and fourth generation EGFR: druglikeness, in silico ADMET, docking, DFT, molecular dynamics simulation, and MMGBSA study;Natural Product Research;2024-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3